Neuroscience research continually provides insight in to improving the human condition. Today, more than ever before there are new business opportunities to bridge science and engineering to help people. Given the complexity of the human brain, it is no small undertaking and often involves academic research, government support, and a determined innovator to create a successful business proposition.
Please join us at the Washington, D.C. French Embassy on Wednesday, March 13 from 6-9pm to hear leaders from France and the U.S. present their perspectives on the public private partnerships that are often essential in creating the opportunities for new businesses in healthcare.
Dr. Oliver Blin, of ISERM and IMI and Stephanie Fertig, SBIR Project Manager, National Institute of Neurological Disorders & Stroke at NIH will give short presentations on the state of neuroscience. They will then be joined by Dr. John Reppas, Director of Public Policy of the Neurotechnology Industry Organization, for a conversation about public-private partnerships.
We will take a break for light refreshments, including French wine.
Dr. Kenneth Carter, Executive Chairman at Neuralstem—a company approved for an FDA phase 1 trial—will discuss his experience as an experienced entrepreneur in this field where it can take a long time to get your product to market.
After a networking break, we will hear several short presentations from entrepreneurs who have started new companies: Dr. Samantha Scott of JuneBrain, Sam Jazzo of Kinometrix, and Dr. Dan Gura of AlgometRx.